3P Biopharmaceuticals, a CDMO specializing in process development and cGMP manufacturing for biologics, opened its first commercial office in Boston, MA. This marks 3P’s first venture outside of Spain, and according to the company, strategically places it at the center of the world´s largest biopharma hub. Dámaso Molero, CEO at 3P said, “The United States is considered one of the largest and most dynamic markets for biopharma worldwide. Establishing ourselves in Boston will allow 3P to ...